Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hawkins, NM
  • Wang, DL
  • Pocock, SJ
  • McMurray, JJV
  • Pfeffer, MA
  • Swedberg, K
  • Granger, CB
  • Yusuf, Salim
  • Dunn, FG

publication date

  • February 1, 2005